Completed
Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study
NCT07105228
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +8 more
- Locations
-
- Regeneron Research Site Tarrytown, New York, United States